Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-19-000241
Filing Date
2019-02-04
Accepted
2019-02-04 12:03:37
Documents
46
Period of Report
2016-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT sibannac_10ka-083116.htm 10-K/A 457369
2 CERTIFICATION sibannac_10ka-ex3101.htm EX-31.1 6728
3 CERTIFICATION sibannac_10ka-ex3102.htm EX-31.2 6831
4 CERTIFICATION sibannac_10ka-ex3201.htm EX-32.1 3773
5 CERTIFICATION sibannac_10ka-ex3202.htm EX-32.2 3840
6 GRAPHIC image_001.jpg GRAPHIC 22897
7 GRAPHIC image_002.jpg GRAPHIC 18082
  Complete submission text file 0001683168-19-000241.txt   1717420

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE snnc-20160831.xml EX-101.INS 206403
9 XBRL SCHEMA FILE snnc-20160831.xsd EX-101.SCH 17599
10 XBRL CALCULATION FILE snnc-20160831_cal.xml EX-101.CAL 22601
11 XBRL DEFINITION FILE snnc-20160831_def.xml EX-101.DEF 47056
12 XBRL LABEL FILE snnc-20160831_lab.xml EX-101.LAB 126240
13 XBRL PRESENTATION FILE snnc-20160831_pre.xml EX-101.PRE 101975
Mailing Address 2122 E. HIGHLAND AVENUE, SUITE 425 PHOENIX AZ 85016
Business Address 2122 E. HIGHLAND AVENUE, SUITE 425 PHOENIX AZ 85016 480-498-8300
Sibannac, Inc. (Filer) CIK: 0001313938 (see all company filings)

EIN.: 330903494 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K/A | Act: 34 | File No.: 000-55578 | Film No.: 19562671
SIC: 2834 Pharmaceutical Preparations